|
PRPS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.265400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.539400E-01 |
| Normal-vs-Stage2 |
2.341200E-01 |
| Normal-vs-Stage3 |
5.947900E-02 |
| Normal-vs-Stage4 |
9.584800E-01 |
| Stage1-vs-Stage2 |
1.698210E-01 |
| Stage1-vs-Stage3 |
5.509600E-02 |
| Stage1-vs-Stage4 |
9.408400E-01 |
| Stage2-vs-Stage3 |
8.151000E-01 |
| Stage2-vs-Stage4 |
4.745000E-01 |
| Stage3-vs-Stage4 |
3.311400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.133000E-01 |
| Normal-vs-AfricanAmerican |
1.915440E-01 |
| Normal-vs-Asian |
6.559400E-01 |
| Caucasian-vs-AfricanAmerican |
4.394600E-01 |
| Caucasian-vs-Asian |
8.190200E-01 |
| AfricanAmerican-vs-Asian |
9.343600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.200800E-01 |
| Normal-vs-Female |
8.890000E-01 |
| Male-vs-Female |
3.497200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.635900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.538600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.263600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.483600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.650400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.190010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.344600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.499600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.365600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.602600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.023600E-01 |
| Normal-vs-Grade 2 |
8.259600E-01 |
| Normal-vs-Grade 3 |
9.867700E-02 |
| Normal-vs-Grade 4 |
4.764800E-01 |
| Grade 1-vs-Grade 2 |
1.880010E-01 |
| Grade 1-vs-Grade 3 |
6.857700E-02 |
| Grade 1-vs-Grade 4 |
1.368380E-01 |
| Grade 2-vs-Grade 3 |
7.868300E-02 |
| Grade 2-vs-Grade 4 |
4.317800E-01 |
| Grade 3-vs-Grade 4 |
9.622200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.418300E-02 |
| Normal-vs-ccB subtype |
3.382100E-04 |
| ccA subtype-vs-ccB subtype |
6.82540000074283E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.811600E-01 |
| Normal-vs-N1 |
6.744600E-01 |
| N0-vs-N1 |
8.220600E-01 |
|
|
